TSX closed
Loading markets…
Stocks/NASDAQ/ALAB

Astera Labs, Inc. (ALAB : NASDAQ)

Common Stock

$179.47

USD

-43.80 (-19.62%)

Last updated: 2026-11-05

Follow ALAB

ALAB

Astera Labs, Inc.

Source:WealthAwesomeWealthAwesome
↓ $185.15 (-50.78%)
30 day period
$179.47$284.63$389.80Sep 25Oct 16Nov 5

Performance

1 Day

-4.43%

1 Week

-24.88%

1 Month

-38.38%

YTD

+24.34%

Key Statistics

Market Cap

$38.73B

52W High

$499.48

52W Low

$97.89

P/E Ratio

92.26

50 Day MA

$306.13

200 Day MA

$255.77

Beta

3.86

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/5/2026$211.41$211.81$177.61$179.47$179.4711,762,895
11/4/2026$217.97$233.53$208.40$223.27$223.278,216,324
11/3/2026$236.19$249.50$231.00$233.62$233.625,335,752
11/2/2026$257.49$257.49$226.00$229.67$229.675,455,625
10/30/2026$271.01$275.00$249.09$258.70$258.707,277,400
10/29/2026$294.16$294.99$279.14$290.43$290.433,042,295
10/28/2026$290.71$300.76$286.00$297.20$297.203,237,291
10/27/2026$267.85$288.30$262.00$286.69$286.694,506,676
10/26/2026$258.27$268.00$249.25$259.51$259.512,932,917
10/23/2026$259.51$266.87$253.44$257.16$257.162,442,000

Analyst Price Targets

Based on 26 analysts covering ALAB · as of Nov 5, 2026

📈

Wall Street analysts forecast ALAB stock price to rise 109.3% over the next 12 months.

Consensus

Buy

4.12 / 5.00

Avg. Target

US$375.66

+109.3% Upside

Previously US$387.57 on Nov 3, 2026

Current Price

US$179.47

Last close

Analyst Breakdown (26 analysts)

Strong Buy 11
Buy 7
Hold 8
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on ALAB's historical volatility

HistoricalForecast68%95%
US$43.30US$138.65US$234.00US$329.35US$424.70US$520.05TodayJul 1Sep 3Nov 5Dec 18Jan 31Mar 15

30-Day Vol

101.5%

Annualized

90-Day Vol

101.8%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

US$150.12

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$169.10US$119.14 – US$240.00
60 trading daysUS$159.33US$97.10 – US$261.42
90 trading daysUS$150.12US$81.86 – US$275.31

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Astera Labs, Inc.

Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure in Taiwan and the United States. It offers an intelligent connectivity platform, comprised of semiconductor-based, high-speed, mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors, and COSMOS. The company provides COSMOS software suite, a connectivity system management and optimization software that enables management and optimization of resources for large fleets at cloud-scale via link, fleet, and RAS management capabilities. In addition, it offers PCIe/CXL smart DSP retimers and cable modules; ethernet smart cable modules for cloud and AI infrastructure; CXL memory connectivity controllers; and smart fabric switches. The company serves hyperscalers and system original equipment manufacturers. Astera Labs, Inc. was incorporated in 2017 and is based in San Jose, California.

Financials

Revenue (TTM)
$1.20B
EBITDA
$285.40M
Profit Margin
30.74%
ROE (TTM)
25.83%
EPS (Diluted)
2.42
Book Value
8.01

Classification

Sector
Information Technology
Industry
Semiconductors & Semiconductor Equipment
Group
Semiconductors & Semiconductor Equipment

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About ALAB.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
INMInMed Pharmaceuticals Inc$17.50+941.67%
OMHOhmyhome Limited Ordinary Shares$15.55+432.53%
CRISCuris Inc$1.11+56.34%
PMAXPowell Max Limited Class A Ordinary Shares$1.04+54.07%
RFAIRRF Acquisition Corp II Right$0.24+50.00%
CRCTCricut Inc$8.88+48.74%
LYELLyell Immunopharma Inc$15.43+43.27%
GENVRGen Digital Inc. Contingent Value Rights$4.03+42.40%

ALAB.US news timeline

13 articles covering ALAB.US, most recent first

Latest

Astera Labs’ Q3 Earnings Decision Headline: What Investors Should Know

•Stocks